PHARMACOLOGY OF NADOLOL (SQ 11725), A BETA-ADRENERGIC ANTAGONIST LACKING DIRECT MYOCARDIAL DEPRESSION

被引：115

作者：

LEE, RJ ^{[1
]}

EVANS, DB ^{[1
]}

BAKY, SH ^{[1
]}

LAFFAN, RJ ^{[1
]}

机构：

[1] SQUIBB INST MED RES, PRINCETON, NJ 08540 USA

来源：

关键词：

D O I：

10.1016/0014-2999(75)90182-X

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：371 / 382

页数：12

共 24 条

[1] SOME QUANTITATIVE USES OF DRUG ANTAGONISTS
ARUNLAKSHANA, O
SCHILD, HO
[J]. BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1959, 14 (01): : 48 - 58
[2] BLACK JW, 1964, LANCET, V1, P1081
[3] EVALUATION OF CARDIAC EFFECTS OF SEVERAL BETA ADRENERGIC BLOCKING AGENTS
BLINKS, JR
[J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1967, 139 (A3) : 673 - &
[4] METABOLISM OF PROPRANOLOL (INDERAL) A POTENT SPECIFIC BETA-ADRENERGIC RECEPTOR BLOCKING AGENT
BOND, PA
[J]. NATURE, 1967, 213 (5077) : 721 - &
[5] PROPRANOLOL INHIBITION OF RENIN SECRETION - SPECIFIC APPROACH TO DIAGNOSIS AND TREATMENT OF RENIN-DEPENDENT HYPERTENSIVE DISEASES
BUHLER, FR
BRUNNER, HR
BAER, L
VAUGHAN, ED
LARAGH, JH
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1972, 287 (24) : 1209 - +
[6] ELIASH S, 1971, BRIT J PHARMACOL, V43, P287
[7] FITZ GERALD JD, 1969, CLIN PHARMACOL THER, V10, P292
[8] GIBSON JK, 1974, PHARMACOLOGIST, V16, P201
[9] HANSSON L, 1973, ACTA MED SCAND, P1
[10] JEWITT DE, 1969, LANCET, V1, P635